Stocks
Sino Biopharmaceutical Limited (SBMFF) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 19 874 | 6 691 | 6 979 | 6 109 | 7 791 | 5 023 | ||
| Changes by years, y/y, % | +251% | -66% | +4% | -12% | +28% | +6.6% | |||
Sino Biopharmaceutical Limited. EBITDA US GAAP, bln rub
Sino Biopharmaceutical Limited. EBITDA US GAAP, changes, %
Sino Biopharmaceutical Limited. EBITDA US GAAP, sum by quarters, bln rub
Sino Biopharmaceutical Limited (SBMFF) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| EBITDA, bln rub | ? | 1 969 | 1 658 | 1 658 | 3 547 | 3 547 | 5 023 | |
| Changes by years, y/y, % | 0% | +52% | +53% | +80% | +80% | |||
| Changes by quarters, q/q, % | 0% | -16% | 0% | +114% | 0% | |||
